Fresenius SE KGaA (Fresenius SE KGaA) Change In Working Capital : $492 Mil (TTM As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Fresenius SE KGaA Change In Working Capital?

Fresenius SE KGaA's change in working capital for the quarter that ended in Dec. 2023 was $955 Mil.

Fresenius SE KGaA's change in working capital for the fiscal year that ended in Dec. 2023 was $479 Mil.

It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement. Not by calculating the number changes in each periods' working capital (Total Current Assets minus Total Current Liabilities).

Fresenius SE KGaA Change In Working Capital Historical Data

The historical data trend for Fresenius SE KGaA's Change In Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fresenius SE KGaA Change In Working Capital Chart

Fresenius SE KGaA Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Working Capital

Get a 7-Day Free Trial

-1,313.33

1,250.61

-603.39

-272.25

478.74

Fresenius SE KGaA Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Working Capital	Get a 7-Day Free Trial															766.95	-996.79	409.53	123.80	955.29

Fresenius SE KGaA Change In Working Capital Calculation

Change In Working Capital for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $492 Mil.

Working Capital is a measure of a company's short term liquidity or its ability to cover short term liabilities. It is defined as the difference between a company's current assets and current liabilities.

Changes in Working Capital is reported in the cash flow statement since it is one of the major ways in which net income can differ from operating cash flow. It is calculated by adding the items under "Change in operating assets and liabilities" (may refer to a different name for different company) section in Cash Flow Statement.

Use Wal-Mart Stores Inc (Jan 2014, Annual Data) as an example: Source: Wal-Mart Stores Inc 2014-01-31 10-K from SEC

Consolidated Statements of Cash Flows	Fiscal Years Ended	January 31,	(Amounts in millions)
Cash flows from operating activities:	2014	2013	2012
Changes in certain assets and liabilities, net of effects of acquisitions:
Receivables, net	(566)	(614)	(796)
Inventories	(1,667)	(2,759)	(3,727)
Accounts payable	531	1,061	2,687
Accrued liabilities	103	271	(935)
Accrued income taxes	(1,224)	981	994

For 2014-01-31, add all the items under 2014 collum together, Change in Working Capital was (566) + (1,667) + 531 + 103 + (1,224) = $ (2,823) Mil.

Fresenius SE KGaA Change In Working Capital Related Terms

Thank you for viewing the detailed overview of Fresenius SE KGaA's Change In Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Fresenius SE KGaA (Fresenius SE KGaA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Fresenius SE & Co KGaA (OTCPK:FSNUY) » Definitions » Change In Working Capital

Comparable Companies

Traded in Other Exchanges

FSNUF:USA FREN:Mexico FRE:Italy FREd:UK 0OO9:UK FRE:Germany FRE:Austria

Address

Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352

Website

https://www.fresenius.com

Fresenius SE is a healthcare holding company based in Germany with four segments. The company owns a large stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals and fertility clinics in Germany, Spain, and Latin America. Vamed provides a variety of services such as healthcare facility construction and operation management, including post-acute care rehabilitation.

Fresenius SE KGaA (Fresenius SE KGaA) Headlines

From GuruFocus

Tweedy Browne Fund's 1st-Quarter Commentary

By Sydnee Gatewood Sydnee Gatewood • 05-04-2021

Tweedy Browne Comments on Fresenius

By Sydnee Gatewood Sydnee Gatewood • 06-01-2021

Top 1st-Quarter Trades of the Tweedy Browne Global Value Fund

By Margaret Moran Margaret Moran • 04-13-2021

Tweedy Brown Comments on Fresenius

By Sydnee Gatewood Sydnee Gatewood • 05-04-2021

Fresenius SE & Co. KGaA to present at the dbVIC - Deutsche Bank ADR Virtual Investor Conference on 13 November 2019

By PRNewswire PRNewswire • 11-07-2019

Fresenius SE KGaA Stock Is Believed To Be Modestly Undervalued

By GF Value GF Value • 04-01-2021

Fresenius SE KGaA Stock Is Estimated To Be Fairly Valued

By GF Value • 07-02-2021